UBS Group’s iKang Healthcare Group, Inc. KANG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-182
| Closed | -$4K | – | 8590 |
|
|
2018
Q4 | $4K | Sell |
182
-1,527
| -89% | -$27.2K | ﹤0.01% | 7688 |
|
|
2018
Q3 | $31K | Buy |
+1,709
| New | +$32.9K | ﹤0.01% | 6526 |
|
|
2018
Q2 | – | Sell |
-1,155
| Closed | -$23K | – | 8473 |
|
|
2018
Q1 | $23K | Sell |
1,155
-203
| -15% | -$3.41K | ﹤0.01% | 6332 |
|
|
2017
Q4 | $21K | Buy |
1,358
+396
| +41% | +$5.72K | ﹤0.01% | 6539 |
|
|
2017
Q3 | $13K | Buy |
+962
| New | +$12.9K | ﹤0.01% | 6752 |
|
|
2017
Q2 | – | Sell |
-1,135
| Closed | -$17K | – | 8227 |
|
|
2017
Q1 | $17K | Buy |
1,135
+443
| +64% | +$7.28K | ﹤0.01% | 6286 |
|
|
2016
Q4 | $12K | Sell |
692
-1,644
| -70% | -$27.8K | ﹤0.01% | 6841 |
|
|
2016
Q3 | $42K | Sell |
2,336
-7,391
| -76% | -$136K | ﹤0.01% | 5667 |
|
|
2016
Q2 | $179K | Buy |
9,727
+1,127
| +13% | +$22.7K | ﹤0.01% | 4618 |
|
|
2016
Q1 | $188K | Sell |
8,600
-1,889
| -18% | -$39.3K | ﹤0.01% | 4527 |
|
|
2015
Q4 | $215K | Buy |
10,489
+197
| +2% | +$3.4K | ﹤0.01% | 4610 |
|
|
2015
Q3 | $153K | Buy |
10,292
+6,605
| +179% | +$107K | ﹤0.01% | 4855 |
|
|
2015
Q2 | $71K | Buy |
3,687
+128
| +4% | +$2.35K | ﹤0.01% | 5689 |
|
|
2015
Q1 | $58K | Sell |
3,559
-203
| -5% | -$3.39K | ﹤0.01% | 5912 |
|
|
2014
Q4 | $57K | Buy |
+3,762
| New | +$67K | ﹤0.01% | 6336 |
|
UBS Group's KANG Position: Q1 2019 in Review
UBS Group sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 182 shares — an estimated $4K sold.
UBS Group first reported a position in KANG in Q4 2014 and held it in 15 quarters. The position peaked at $215K in Q4 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.
- UBS Group reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
- UBS Group sold 182 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $4K.
- UBS Group first reported a position in iKang Healthcare Group, Inc. in Q4 2014 and held it in 15 quarters.
- UBS Group's iKang Healthcare Group, Inc. position peaked at $215K in Q4 2015.
- 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.
Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.